Director, Commercial Financial Planning & Analysis
Disc Medicine
Summary
The Director, Commercial Financial Planning & Analysis (FP&A) will lead FP&A activities to support the Commercial organization and its associated functions. Reporting to the VP of FP&A, this newly created role will develop financial plans and, through insightful analysis and reporting, provide transparent visibility into actual operating expenses and forecasts. The Director will manage the planning processes and serve as the finance business partner to the Commercial organization.
Job description
Position Overview
The Director, Commercial Financial Planning & Analysis (FP&A) will lead FP&A activities to support the Commercial organization and its associated functions. Reporting to the VP of FP&A, this newly created role will develop financial plans and, through insightful analysis and reporting, provide transparent visibility into actual operating expenses and forecasts. The Director will manage the planning processes and serve as the finance business partner to the Commercial organization.
Responsibilities
- Trusted business partner to support the Commercial organization and related functions
- Understand the key drivers of business performance and their financial implications
- Serve as the financial point person for Commercial department leaders, supporting prioritization efforts and spending trade-offs
- Develop business insights and produce KPIs in partnership with the Commercial Operations team
- Recommend monthly and quarterly accruals to the Accounting team
- Work closely with Accounting to ensure accurate and timely monthly and quarterly financial results
- Lead the monthly financial analysis for the Commercial organization as a key contributor to the financial close
- Lead/support key Commercial financial related projects and initiatives
- Lead the annual budgeting, quarterly reforecasts and long-range plan processes for Commercial functions and product launch leads
- Work with internal stakeholders to create robust functional financial plans
- Present to leadership on the high-level drivers and story based on data
- Lead monthly and quarterly variance analysis for actual and forecasted results
- Develop and maintain quarterly function and program management reporting, analytical reviews, trend analysis and dashboards for the Executive Team & BoD
- Assess the revenue model and forecast, working with Commercial to review them and provide insights and recommendations
- Assess gross-to-net (GtN) actuals in partnership with Accounting
- Review material business terms and conditions for Commercial, including vendor agreements, contracts and purchase requisitions
- Partner with Accounting to support monthly and quarter-end close processes
- Partner with Project Launch Management to ensure key activities and drivers are aligned
- Create, track, and report monthly headcount and related cost trends
- Maintain headcount model in Planful and provide various analytics / scenarios
- Provide management KPI and performance highlights (MD&A)
Requirements
- Bachelor's degree in Finance and/or Accounting required
- MBA, CPA certification and/or consulting experience highly preferred
- 12+ years of relevant work and FP&A experience in the biotech/life sciences sector, particularly in public companies
- Track record of success in small to mid-size biotech environments
- Experience providing best-in-class FP&A support to a growing Commercial organization
- Financial experience in a commercial company with revenue, cost of goods sold, and gross margin
- Proven expertise in developing comprehensive commercial models
- Experience with planning software systems such as Planful or Adaptive Planning
- Advanced Microsoft Excel and PowerPoint skills; expertise with a variety of financial software systems (e.g., NetSuite)
- Financial statement knowledge and understanding of US GAAP
- Excellent communication and strong interpersonal skills
- Excellent project management skills and the ability to collaborate cross-functionally
Requirements
- Bachelor's degree in Finance and/or Accounting required
- MBA, CPA certification and/or consulting experience highly preferred
- 12+ years of relevant work and FP&A experience in the biotech/life sciences sector, particularly in public companies
- Track record of success in small to mid-size biotech environments
- Experience providing best-in-class FP&A support to a growing Commercial organization
- Financial experience in a commercial company with revenue, cost of goods sold, and gross margin
- Proven expertise in developing comprehensive commercial models
- Experience with planning software systems such as Planful or Adaptive Planning
- Advanced Microsoft Excel and PowerPoint skills
- Expertise with a variety of financial software systems (e.g., NetSuite)
- Financial statement knowledge and understanding of US GAAP
- Excellent communication and strong interpersonal skills
- Excellent project management skills and the ability to collaborate cross-functionally
Benefits
- Comprehensive benefits
- Competitive compensation packages
- Flexible work environment
Company overview
Disc Medicine is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with serious hematologic disorders. Headquartered in Watertown, Massachusetts, the company focuses on discovering, developing, and commercializing novel treatments that target fundamental pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. With a specialized focus on hematology, Disc Medicine is building a unique portfolio of innovative, first-in-class therapeutic candidates designed to address a wide spectrum of blood disorders ranging from rare genetic conditions like erythropoietic protoporphyria (EPP) to complex blood cancers such as myelofibrosis and polycythemia vera. The company's pipeline includes promising candidates like bitopertin for EPP and DISC-0974 for anemia of myelofibrosis, with several programs advancing through clinical trials. Disc Medicine operates with a team of experienced scientists and industry veterans who bring deep expertise in drug development from discovery through commercialization, demonstrating a commitment to scientific rigor and patient-focused innovation in the hematology space.